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PCR analyses were performed with whole 
genomic DNA from all case isolates. Prim-
ers used for analysis of blaVIM /blaIMP genes 
were Vim F/R, Imp F/R respectively. PCR 
primers were designed and PCR conditions 
were performed as previously described.3 As-
sociation of integrons with MBL genes was 
confirmed by PCR using combination of bla-
and integron-specific primers as described 
previously.4
PCR products of blaVIM/blaIMP were elec-
trophoresed on a 1.5% agarose gel. Nucleo-
tide sequencing was performed directly on 
cloned fragments using an ABI Prism 377 
DNA sequencer. Sequence homology was 
performed using the BLAST program avail-
able at the website of the National Center of 
Biotechnology Information.
PCR using the VIM forward and VIM 
reverse yielded an internal fragment of ap-
proximately 650 bp suggesting the presence 
of a blaVIM gene, and sequencing of its PCR 
product was consistent with blaVIM-2, while 
no other metallo-β-lactamases was detect-
ed. Furthermore, by combining the primer 
attI1 with VIM-R and attI1 with VIM-F, col-
inearity of blaVIM-2 genes with class 1 inte-
grons was detected in all isolates.5
Genomic DNA, prepared as described 
previously and digested with SpeI was sub-
jected to PFGE with the CHEF DRIII. Com-
parison of the PFGE profiles with those 
strains isolated in burn wards indicated that 
the epidemic strains were identical (data 
not shown).6
The emergence of the blaVIM-2 gene at 
the hospital was rapid, and the patients 
had strong epidemiological links. In ad-
dition, the blaVIM-2 – carrying isolates, 
which were recovered from the eight pa-
tients during the single hospitalization, 
were the same strain, suggesting a nosoco-
mial transmission. The spreading of car-
Dear Editor, 
We reported the outbreak of a Pseudomonas 
aeruginosa strain producing VIM-2 type MBLs 
in burn wards, which happened after the trans-
fer of a patient with P. aeruginosa infection. 
The outbreak of carbapenem-resistant 
P. aeruginosa occurred in four different 
burn wards of the Jilin Factory Hospital in 
China during the period of July to Septem-
ber 2006. The first carbapenem-resistant 
P. aeruginosa strain was isolated from the 
burn culture of a 6 year-old child at admis-
sion. The patient was transferred from a lo-
cal hospital for burn injury on the leg. He 
had received broad-spectrum antibiotics, 
including ampicillin-sulbactam and piper-
acillin-tazobactam at the local hospital. 
His antibiotic was switched to impenem for 
pneumonia coverage, admitted to the gen-
eral burn ward. After one week, blood and 
burn cultures yielded P. aeruginosa isolates 
susceptible only to aztreonam and he died 
from sepsis and multiple-organ failure soon 
thereafter. Subsequently, the carbapenem-
resistant P. aeruginosa strain was recovered 
in seven other patients hospitalized in the 
general burn ward. 
A total of eight clinical isolates of carbap-
enem-resistant P. aeruginosa were consecu-
tively recovered from patients hospitalized 
at the burn wards. Routine antibiograms 
were performed by the disk diffusion meth-
od according to the guidelines of the Clini-
cal and Laboratory Standards Institutes.1 
The resistance patterns of the eight strains 
are illustrated in Table 1. Among the anti-
microbial agents tested, four isolates were 
only susceptible to ciprofloxacin and az-
treonam. Metallo-β-lactamases production 
was evaluated using the imipenem-EDTA 
disk method.2 All isolates were positive in 
the EDTA disc synergy test indication the 
presence of an MBL.
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Table 1. Antimicrobial susceptibility patterns of MBL-producing Pseudomonas aeruginosa (PA) isolates
Strain No. MIC (µg/mL) Disc diffusion test
 TIC TCC ATM CAZ IMP CTX FEP GEN TOB AMK CIP CHL SXT
PA 1 > 256 > 256 64 > 256 64 > 128 > 128 R R R R R R
PA 2 > 256 > 256 64 > 256 64 > 128 > 128 R R R R R R
PA 3 > 256 > 256 64 > 256 64 > 128 > 128 R R R R R R
PA 4 > 256 > 256 64 > 256 64 > 128 > 128 R R R R R R
PA 5 > 256 > 256 8 > 256 32 > 128 > 128 R R R S R R
PA 6 > 256 > 256 8 > 256 32 > 128 > 128 R R R S R R
PA 7 > 256 > 256 8 > 256 32 > 128 > 128 R R R S R R
PA 8 > 256 > 256 8 > 256 32 > 128 > 128 R R R S R R
CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; ATM, aztreonam; IMP, imipenem; TIC, ticarcillin; TCC, ticarcillin plus clavu-
lanic acid; CHL, chloramphenicol; GEN, gentamycin; TOB, tobramycin; AMK, amikacin; CIP, ciprofloxacin; SXT, sulfamethoxazole-
trimethoprim; S, susceptible, R, resistant.
bapenem resistance, mediated by VIM-2 MBL in 
P. aeruginosa isolates in burn wards, is largely due to clon-
al expansion of a VIM-2-carrying strain throughout the 
burn wards, which was carried on a mobile gene cassette 
inserted into a class 1 integron located on the bacterial 
chromosome. 
Contaminated hands of health personnel and colo-
nized or infected patients are sources of infection. 
Therefore, constant glove changing between patients 
and proper hand sanitization should be enforced.7
Follow-up testing did not reveal the presence of the 
epidemic strains in burn wards as well as in the hospital 
settings studies for the following half year.
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